Nippon Shinyaku Drug Patent Portfolio
Nippon Shinyaku owns 1 orange book drug protected by 2 US patents Given below is the list of Nippon Shinyaku's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10870676 | Antisense nucleic acids | 31 Aug, 2031 | Active |
| US9079934 | Antisense nucleic acids | 31 Aug, 2031 | Active |
Latest Legal Activities on Nippon Shinyaku's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Nippon Shinyaku.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Year, Large Entity | 05 Jun, 2024 | US10870676 |
| transaction for FDA Determination of Regulatory Review Period | 08 Dec, 2023 | US9079934 |
| transaction for FDA Determination of Regulatory Review Period | 30 Nov, 2023 | US9079934 |
| Second letter to regulating agency to determine regulatory review period | 26 Jan, 2023 | US9079934 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 28 Dec, 2022 | US9079934 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 21 Dec, 2022 | US9079934 |
|
Email Notification
Critical
| 21 Dec, 2022 | US9079934 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 14 Nov, 2022 | US10870676 |
|
Email Notification
Critical
| 14 Nov, 2022 | US10870676 |
|
Correspondence Address Change
Critical
| 30 Sep, 2022 | US10870676 |
| Letter from FDA or Dept of Agriculture re PTE application | 24 Aug, 2022 | US9079934 |
| Initial letter Re: PTE Application to regulating agency | 02 Mar, 2021 | US9079934 |
| Sequence Moved to Public Database | 22 Dec, 2020 | US10870676 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 22 Dec, 2020 | US10870676 |
|
Recordation of Patent Grant Mailed
Critical
| 22 Dec, 2020 | US10870676 |
Nippon Shinyaku's Family Patents
Nippon Shinyaku Drug List
Given below is the complete list of Nippon Shinyaku's drugs and the patents protecting them.
1. Viltepso
Viltepso is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10870676 | Antisense nucleic acids |
31 Aug, 2031
(6 years from now)
| Active |
| US9079934 | Antisense nucleic acids |
31 Aug, 2031
(6 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Viltepso's drug page